Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 238

1.

A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.

Kim SS, Harford JB, Moghe M, Slaughter T, Doherty C, Chang EH.

Int J Cancer. 2019 Jun 26. doi: 10.1002/ijc.32531. [Epub ahead of print]

PMID:
31241175
2.

Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.

Kim M, Kim BH, Kim JM, Kim EH, Kim K, Pak K, Jeon YK, Kim SS, Park H, Kang T, Lee BJ, Kim IJ.

Cancer. 2019 Jun 19. doi: 10.1002/cncr.32166. [Epub ahead of print]

PMID:
31216369
3.

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.

Gunaratne PH, Pan Y, Rao AK, Lin C, Hernandez-Herrera A, Liang K, Rait AS, Venkatanarayan A, Benham AL, Rubab F, Kim SS, Rajapakshe K, Chan CK, Mangala LS, Lopez-Berestein G, Sood AK, Rowat AC, Coarfa C, Pirollo KF, Flores ER, Chang EH.

Cancer. 2019 Jul 15;125(14):2409-2422. doi: 10.1002/cncr.32053. Epub 2019 Apr 23.

PMID:
31012964
4.

The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults.

Kim JM, Kim BH, Lee H, Kim EH, Kim M, Kim JH, Jeon YK, Kim SS, Kim IJ, Kim YK.

Diabetes Metab J. 2019 Apr 3. doi: 10.4093/dmj.2018.0130. [Epub ahead of print]

5.

Circulating Cell-Free mtDNA Contributes to AIM2 Inflammasome-Mediated Chronic Inflammation in Patients with Type 2 Diabetes.

Bae JH, Jo SI, Kim SJ, Lee JM, Jeong JH, Kang JS, Cho NJ, Kim SS, Lee EY, Moon JS.

Cells. 2019 Apr 8;8(4). pii: E328. doi: 10.3390/cells8040328.

6.

Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy.

Kim EH, Jeon YK, Pak K, Kim IJ, Kim SJ, Shin S, Kim BH, Kim SS, Lee BJ, Lee JG, Goh TS, Kim K.

J Bone Metab. 2019 Feb;26(1):31-38. doi: 10.11005/jbm.2019.26.1.31. Epub 2019 Feb 28.

7.

Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?

Kim TH, Park JW, Kim BH, Kim H, Moon SH, Kim SS, Woo SM, Koh YH, Lee WJ, Kim DY, Kim CM.

Cancers (Basel). 2019 Feb 15;11(2). pii: E230. doi: 10.3390/cancers11020230.

8.

Glial TLR2-driven innate immune responses and CD8+ T cell activation against brain tumor.

Chang CY, Jeon SB, Yoon HJ, Choi BK, Kim SS, Oshima M, Park EJ.

Glia. 2019 Jun;67(6):1179-1195. doi: 10.1002/glia.23597. Epub 2019 Feb 5.

PMID:
30720218
9.

Loss of BRCA1 Spontaneously Induces the Tumorigenesis in Lacrimal Gland.

Kim SE, Baek HJ, Park EJ, Lim SC, Kim SS.

Anal Cell Pathol (Amst). 2018 Dec 17;2018:8120579. doi: 10.1155/2018/8120579. eCollection 2018.

10.

Extracellular Vesicle-Mimetic Ghost Nanovesicles for Delivering Anti-Inflammatory Drugs to Mitigate Gram-Negative Bacterial Outer Membrane Vesicle-Induced Systemic Inflammatory Response Syndrome.

Go G, Lee J, Choi DS, Kim SS, Gho YS.

Adv Healthc Mater. 2019 Feb;8(4):e1801082. doi: 10.1002/adhm.201801082. Epub 2018 Dec 14.

PMID:
30549424
11.

Inhibition of AKT suppresses the initiation and progression of BRCA1-associated mammary tumors.

Baek HJ, Kim SE, Kim JK, Shin DH, Kim TH, Kim KG, Deng CX, Kim SS.

Int J Biol Sci. 2018 Oct 3;14(13):1769-1781. doi: 10.7150/ijbs.29242. eCollection 2018.

12.

Inhibition of Estrogen Signaling Reduces the Incidence of BRCA1-associated Mammary Tumor Formation.

Baek HJ, Kim SE, Choi EK, Kim JK, Shin DH, Park EJ, Kim TH, Kim JY, Kim KG, Deng CX, Kim SS.

Int J Biol Sci. 2018 Oct 3;14(12):1755-1768. doi: 10.7150/ijbs.28142. eCollection 2018.

13.

WITHDRAWN: Application of deep learning to predict advanced neoplasia using big clinical data in colorectal cancer screening of asymptomatic adults.

Yang HJ, Cho CW, Kim SS, Ahn KS, Park SK, Park DI.

Gastrointest Endosc. 2018 Nov 4. pii: S0016-5107(18)33254-1. doi: 10.1016/j.gie.2018.10.041. [Epub ahead of print]

PMID:
30403965
14.

Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors.

Choi EK, Lim JA, Kim JK, Jang MS, Kim SE, Baek HJ, Park EJ, Kim TH, Deng CX, Wang RH, Kim SS.

Exp Mol Med. 2018 Oct 16;50(10):136. doi: 10.1038/s12276-018-0169-z.

15.

Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor.

Kim SS, Harford JB, Moghe M, Rait A, Chang EH.

Oncoimmunology. 2018 Aug 1;7(10):e1484982. doi: 10.1080/2162402X.2018.1484982. eCollection 2018.

16.

The expression of two isoforms of matrix metalloproteinase-2 in aged mouse models of diabetes mellitus and chronic kidney disease.

Rhee H, Han M, Kim SS, Kim IY, Lee HW, Bae SS, Ha HK, Jung ES, Lee MY, Seong EY, Lee DW, Lee SB, Lovett DH, Song SH.

Kidney Res Clin Pract. 2018 Sep;37(3):222-229. doi: 10.23876/j.krcp.2018.37.3.222. Epub 2018 Sep 30.

17.

The two isoforms of matrix metalloproteinase- 2 have distinct renal spatial and temporal distributions in murine models of types 1 and 2 diabetes mellitus.

Kim IY, Kim SS, Lee HW, Bae SS, Ha HK, Jung ES, Lee MY, Han M, Rhee H, Seong EY, Lee DW, Lee SB, Lovett DH, Song SH.

BMC Nephrol. 2018 Sep 25;19(1):248. doi: 10.1186/s12882-018-1029-8.

18.

Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition.

Huang H, Lee SH, Sousa-Lima I, Kim SS, Hwang WM, Dagon Y, Yang WM, Cho S, Kang MC, Seo JA, Shibata M, Cho H, Belew GD, Bhin J, Desai BN, Ryu MJ, Shong M, Li P, Meng H, Chung BH, Hwang D, Kim MS, Park KS, Macedo MP, White M, Jones J, Kim YB.

J Clin Invest. 2018 Dec 3;128(12):5335-5350. doi: 10.1172/JCI63562. Epub 2018 Oct 29.

19.

Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy.

Kim K, Kim IJ, Pak K, Kim SJ, Shin S, Kim BH, Kim SS, Lee BJ, Jeon YK.

J Clin Endocrinol Metab. 2018 Nov 1;103(11):4232-4240. doi: 10.1210/jc.2017-02704.

PMID:
29982711
20.

Prevalence of BRAFV600E Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAFV600E Prevalent Area.

Kim H, Kim BH, Kim YK, Kim JM, Oh SY, Kim EH, Lee MJ, Kim JH, Jeon YK, Kim SS, Lee BJ, Kim YK, Kim IJ.

J Korean Med Sci. 2018 Jan 24;33(27):e75. doi: 10.3346/jkms.2018.33.e75. eCollection 2018 Jul 2.

Supplemental Content

Loading ...
Support Center